HGS/GSK On Track To Initiate Lymphostat-B Phase III Study In 2006
Full Phase II study results show promise in treatment of lupus even though Lymphostat-B did not meet primary endpoints, the firm says.
Full Phase II study results show promise in treatment of lupus even though Lymphostat-B did not meet primary endpoints, the firm says.